13
Participants
Start Date
March 31, 2009
Primary Completion Date
June 30, 2010
Study Completion Date
October 31, 2011
paclitaxel, gemcitabine, lapatinib
Patients receive paclitaxel and gemcitabine intravenously (iv) on day 1 and 8, and oral lapatinib once daily. Lapatinib with fixed dose will be given once a day p.o. from day 1 without resting during each cycle. The starting doses of paclitaxel 80mg/m2 and gemcitabine 1000mg/m2 iv, on day 1 and 8, and lapatinib 1000mg p.o., daily (dose level 1) will be administered every 21 days.
National Cancer Center, Goyang-si
Collaborators (2)
GlaxoSmithKline
INDUSTRY
HK inno.N Corporation
INDUSTRY
Jungsil Ro
OTHER_GOV